ClinicalTrials.gg
CompletedNCT06993363Updated Jan 29, 2026

Kinesotaping and Strengthening Exercises in Treatment of Osgood-Schlatter Disease

An interventional study of Quadriceps Strengthening and Hamstring and calf stretching exercise in Osgood-Schlatter Disease, sponsored by Cairo University. Completed at 1 site in Egypt. Open to participants aged 18 Years to 25 Years. Per ClinicalTrials.gov, last updated 2026-01-29.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 25 Years
Sex
All
01

Study summary

The purpose of this study is to investigate the effect of adding kinesotaping to quadriceps strengthening exercises on muscle strength, pain, function and range of motion of knee joint in patients with Osgood-Schlatter disease (OSD).

Read the detailed description

60 patients will be participated in this study. The patients of both genders with age ranges from 18 -25 years old. The sample will randomly be divided into two groups.

Group A: will receive strengthening exercise for quadriceps muscle and stretching exercises for hamstring and calf muscles Group B: will receive kinesoatping, strengthening exercises for quadriceps muscle and stretching exercises for hamstring and calf muscles .

All subject will receive the treatment for 6 weeks, All subjects will assign consent form before starting this study and will be explained the purpose of this study before any application.

Outcome measurements:

  1. Quadriceps muscles strength will be assessed by hand held dynamotor.
  2. Pain intensity will be measured by visual analog scale.
  3. Disability function of knee will be measured by lower extremity functional scale (LEFS-Ar).
  4. Range of motion of knee joint will be measured by smart phone application for range of motion measurement.

Data will be collected prior to first session as pre-test measure and at the end of last treatment session as post-test treatment.

02

Conditions studied

  • Osgood-Schlatter Disease

Browse trials for

Keywords

  • Osgood-Schlatter disease
  • Knee function
  • kinesotaping
  • strengthening exercises
03

In context

Osteochondrosis

16 studies on the registry are indexed under Osteochondrosis; 5 are open to participants now.

This study's enrollment of 60 is above the median of 51 across 13 interventional studies indexed under Osteochondrosis.

Browse Osteochondrosis studies →

Lead sponsor

Cairo University is the lead sponsor of 4,941 studies on the registry; 1,458 are open to participants now.

Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

1 - Age - 18 years to 25 years 2. Knee Osgood schlatter disease as per diagnosed by orthopaedisit 3. Duration of knee pain is 4-5 weeks during 6 months prior to study. 4- patients from both gender 5- from 18 Kg/M2 to 25 Kg/M2

Exclusion criteria

Exclusion Criteria:

  1. History of low back pain.
  2. Trauma to the knee joint.
  3. Loss of joint play in tibiofemoral and patellofemoral articulations.
  4. Lower extremity fracture and surgery.
  5. Neurological deficit or movement disorder.
  6. If they had meniscal symptoms.
  7. If they had rheumatoid.
  8. If they had osteoarthritis.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
60 participants (actual)

Study arms

  • Active comparator
    Group A

    Patients will receive strengthening exercises to quadriceps muscle and stretching exercises to hamstring and calf muscles

    Other: Quadriceps Strengthening · Other: Hamstring and calf stretching exercise

  • Experimental
    Group B

    Patients will receive kinesotaping, strengthening exercises to quadriceps muscle and stretching exercises to hamstring and calf muscles

    Other: Quadriceps Strengthening · Other: Hamstring and calf stretching exercise · Other: Kinesotaping application

Interventions

  • OtherQuadriceps Strengthening

    Static Quad Pull the toes up towards your shin, push your knee into the bed to tighten the quad muscles. This should cause your heel to slightly lift off the bed. Hold for 7 seconds. Repeat on affected leg. Straight leg raising * Lie on back with hips square and legs laid out comfortably on the floor * Bend the knee of non-injured leg at a 90-degree angle, planting the foot flatly on the floor. * Stabilize the muscles on your straight leg by contracting your quadriceps (the group of muscles on the front of your thigh). * Inhaling slowly, lift the straight leg six inches off the ground. * Hold for three seconds. * Exhaling slowly, lower the leg to the floor with control * Relax and repeat 10 times more.

  • OtherHamstring and calf stretching exercise

    Hamstring stretching exercise will be done in the long sitting position. The patient will be instructed to keep his affected knee always extended while folding the other leg to the side then he will bend his trunk forward as much as he could in order to touch his toes by his fingers. Calf muscle stretching: The patient will be positioned in the long-sitting with the knees extended. The patient will be instructed to pull his foot into dorsiflexion as much as he could with the assistance of a rolled towel holding this position for 30 seconds (Fig14). The patient will then be instructed to go back to starting position and relax for 30 seconds. This exercise will be done 5 times per session.

  • OtherKinesotaping application

    1 full 25cm strip of KT Tape cut in half. Apply one hour before beginning activity. Clean dirt, oils and lotions from area. After application rub tape vigorously to activate adhesive. Bend the knee at a 90 degree angle Anchor the middle of a half strip of tape diagonally over the point of pain with 80% stretch. Apply ends of tape without stretch. Anchor the middle of a second half strip across the first strip to form an X pattern over the point of pain with 80% stretch.

06

What researchers measure

Primary outcomes

  1. Change in muscle strength

    Quadriceps muscle strength will be assessed by hand held dynamo-meter.

    Time frame: at first week and after 6 weeks of treatment

Secondary outcomes

  1. Change in Pain level

    Pain threshold will be assessed by visual analogue scale

    Time frame: at first week and after 6 weeks of treatment

  2. Change in functional disability

    Functional disability will assessed by lower extremity functional scale

    Time frame: at first week and after 6 weeks of treatment

  3. Knee joint range of motion

    11\. Knee range of motion (flexion, extension) will be assessed by smart phone application (Doctor Goniometer) for range of motion measurement.

    Time frame: at first week and after 6 weeks of treatment

07

Study locations

1 site
  • Physical therapy College - Cairo university
    Cairo, Egypt
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 29, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06993363
Lead sponsor
Cairo University
Responsible party
Doaa Rafat (Assisstant professor of physical therapy, Cairo University) — Principal investigator
First posted
May 28, 2025
Start date
Jul 1, 2025
Primary completion
Nov 30, 2025
Completion
Dec 30, 2025
Last update
Jan 29, 2026

Study contacts

Neveen Abdelatif Professor of physical therapy - Cairo University, Professor
study chair · Department of Basic sciences for physical therapy, Faculty of Physical Therapy , Cairo university, Cairo, Egypt

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion